Ignorance, Persecution, and HIV

This issue of The Scientist focuses on HIV-AIDS. While we concentrate on the struggle for full scientific understanding of the virus and the disease, the essential backdrop remains the scale of the ongoing epidemic and the misery that it causes: Every six seconds another person becomes infected with HIV; every day 8,500 people die of AIDS. Even with the relative success of highly active antiretroviral therapy (HAART), infection is controlled rather than conquered. Moreover, HAART has side effect

Written byRichard Gallagher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This issue of The Scientist focuses on HIV-AIDS. While we concentrate on the struggle for full scientific understanding of the virus and the disease, the essential backdrop remains the scale of the ongoing epidemic and the misery that it causes: Every six seconds another person becomes infected with HIV; every day 8,500 people die of AIDS. Even with the relative success of highly active antiretroviral therapy (HAART), infection is controlled rather than conquered. Moreover, HAART has side effects ranging from the unpleasant to the dangerous, and its long-term effects have yet to be discovered. The ability of HIV to form deadly dormant reservoirs in the body is the subject of the Feature on p. 20.

In addition to the direct devastation wreaked by the virus, there are attendant, indirect costs, the results of ignorance or persecution. Twenty-some years into the epidemic, superstition, paranoia, and denial continue to be regular responses ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies